lc
Lv41
450 积分
2022-07-25 加入
-
The Future of Hypertension Pharmacotherapy: Ongoing and Future Clinical Trials for Hypertension
5小时前
待确认
-
Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study
5小时前
已完结
-
A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies
7天前
已完结
-
Bioengineered Nanomedicines Targeting the Intestinal Fc Receptor Achieve the Improved Glucoregulatory Effect of Semaglutide in a Type 2 Diabetic Mice Model
7天前
已完结
-
Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study
7天前
已完结
-
Optimization of Protein and Peptide Drugs Based on the Mechanisms of Kidney Clearance
1个月前
已完结
-
Predicting Distribution Coefficients (LogD) of Cyclic Peptides Using Molecular Dynamics Simulations
1个月前
已完结
-
Beware of extreme calculated lipophilicity when designing cyclic peptides
1个月前
已完结
-
An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study
2个月前
已完结
-
Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis
2个月前
已完结